Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Schulz

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggeringAlexander D Edwards, Shivanthi P Manickasingham, Roman Spörri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Serum levels of carboxy-terminal telopeptide of type-I collagen are elevated in patients with multiple myeloma showing skeletal manifestations in magnetic resonance imaging but lacking lytic bone lesions in conventional radiographyChristian Jakob, Ivana Zavrski, Ulrike Heider, et al.
Journal of Virology|August 7, 2009
Activation of MDA5 requires higher-order RNA structures generated during virus infectionAndreas Pichlmair, Oliver Schulz, Choon-Ping Tan, et al.
Cell Host & Microbe|May 19, 2010
Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrityOliver Schulz, Andreas Pichlmair, Jan Rehwinkel, et al.
Anticancer Research|August 27, 2011
The mTOR inhibitor RAD001 sensitizes tumor cells to the cytotoxic effect of carboplatin in breast cancer in vitroHongyu Liu, Chuanbing Zang, Jan-Hendrik Schefe, et al.
Journal of Alzheimer'S Disease : JAD|January 30, 2010
A versatile high throughput screening system for the simultaneous identification of anti-inflammatory and neuroprotective compoundsElizabeth Hansen, Martina Krautwald, Annette E Maczurek, et al.
Anti-Cancer Drugs|December 23, 2004
Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trialPeter Schmid, Jutta Krocker, Carsten-Oliver Schulz, et al.
The Journal of Clinical Investigation|April 17, 2012
The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected miceSantiago Zelenay, Anna M Keller, Paul G Whitney, et al.
Cell|February 11, 2010
RIG-I detects viral genomic RNA during negative-strand RNA virus infectionJan Rehwinkel, Choon Ping Tan, Delphine Goubau, et al.
Science (New York, N.Y.)|September 26, 2015
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cellsNader Yatim, Hélène Jusforgues-Saklani, Susana Orozco, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggeringAlexander D Edwards, Shivanthi P Manickasingham, Roman Spörri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Serum levels of carboxy-terminal telopeptide of type-I collagen are elevated in patients with multiple myeloma showing skeletal manifestations in magnetic resonance imaging but lacking lytic bone lesions in conventional radiographyChristian Jakob, Ivana Zavrski, Ulrike Heider, et al.
Journal of Virology|August 7, 2009
Activation of MDA5 requires higher-order RNA structures generated during virus infectionAndreas Pichlmair, Oliver Schulz, Choon-Ping Tan, et al.
Cell Host & Microbe|May 19, 2010
Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrityOliver Schulz, Andreas Pichlmair, Jan Rehwinkel, et al.
Anticancer Research|August 27, 2011
The mTOR inhibitor RAD001 sensitizes tumor cells to the cytotoxic effect of carboplatin in breast cancer in vitroHongyu Liu, Chuanbing Zang, Jan-Hendrik Schefe, et al.
Journal of Alzheimer'S Disease : JAD|January 30, 2010
A versatile high throughput screening system for the simultaneous identification of anti-inflammatory and neuroprotective compoundsElizabeth Hansen, Martina Krautwald, Annette E Maczurek, et al.
Anti-Cancer Drugs|December 23, 2004
Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trialPeter Schmid, Jutta Krocker, Carsten-Oliver Schulz, et al.
The Journal of Clinical Investigation|April 17, 2012
The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected miceSantiago Zelenay, Anna M Keller, Paul G Whitney, et al.
Cell|February 11, 2010
RIG-I detects viral genomic RNA during negative-strand RNA virus infectionJan Rehwinkel, Choon Ping Tan, Delphine Goubau, et al.
Science (New York, N.Y.)|September 26, 2015
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cellsNader Yatim, Hélène Jusforgues-Saklani, Susana Orozco, et al.
Pageof 6